课题基金 / 基金详情

项目摘要

项目成果

Tobias Ritter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this grant application, we propose to develop and optimize two new fluorine-18 (18F) reactions for the synthesis of 18F-labeled small molecules as useful, generally available tools for positron emission tomography (PET). Our goal is to provide readily available reagents that can be used by the entire radiochemistry community for the robust and simple synthesis of 18F-fluorinated probes from readily available materials. Our preliminary data suggest that the proposed reactions combine the simplicity of conventional fluorination chemistry with the large substrate scope of modern late-stage fluorination reactions. Our approach is enabled by novel chemical reactivity that can convert available materials directly into the corresponding fluorinated analogs. Positron emission tomography (PET) is a non-invasive, high sensitivity imaging technology that can be used to diagnose and study human diseases. PET can provide information about normal or aberrant human physiology and is a powerful tool for monitoring disease progression and treatment response. Over the past decade, PET imaging has had an impact in studying several diseases, such as cancer and neurological diseases, and is also beginning to expedite the development of new pharmaceuticals. However, the vast majority of molecules (even those that contain fluorine) cannot currently be labeled with the positron-emitting 18F isotope necessary for imaging. A clear need exists for more versatile and robust radiochemistry methods for incorporation of the 18F isotope. Our lab has invented a new reagent and a new reaction to incorporate the positron-emitting nuclide 18F into molecules based on new chemical reactivity. We have already demonstrated that we can provide aryl and alkyl fluorides from readily available phenols and alcohols, respectively. We propose here reaction development to furnish practical, readily performed methods for the synthesis of PET probes. Reaction optimization will be guided by a mechanism-based approach. We will showcase the utility and generality of our new methods by preparing eight radiotracers that are challenging to prepare with conventional methods.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/ja3125405
发表时间: 2013-02-20
期刊: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子: 15
作者: [Sladojevich, Filippo, Arlow, Sophie I., Tang, Pingping, Ritter, Tobias]
通讯作者: Ritter, Tobias
DOI: 10.1021/op500121w
发表时间: 2014-08-15
期刊: Organic process research & development
影响因子: 3.4
作者: [Fujimoto T, Becker F, Ritter T]
通讯作者: Ritter T
DOI: 10.1002/anie.201500902
发表时间: 2015-05-04
期刊: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子: 16.6
作者: [Shen, Xiao, Neumann, Constanze N., Kleinlein, Claudia, Goldberg, Nathaniel W., Ritter, Tobias]
通讯作者: Ritter, Tobias
DOI: 10.1021/ja405919z
发表时间: 2013-09-25
期刊: Journal of the American Chemical Society
影响因子: 15
作者: [Mazzotti AR, Campbell MG, Tang P, Murphy JM, Ritter T]
通讯作者: Ritter T
19
    Organometallic Chemistry for Applications in Biomedical Sciences
    • 批准号:
      8601710
    • 项目类别:
    • 资助金额:
      $32.38万
    • 财政年份:
      2010
    • 负责人:
      Tobias Ritter
    • 依托单位:
    Organometallic Chemistry for Applications in Biomedical Sciences
    • 批准号:
      8207914
    • 项目类别:
    • 资助金额:
      $32.41万
    • 财政年份:
      2010
    • 负责人:
      Tobias Ritter
    • 依托单位:
    Organometallic Chemistry for Applications in Biomedical Sciences
    • 批准号:
      8401547
    • 项目类别:
    • 资助金额:
      $31.26万
    • 财政年份:
      2010
    • 负责人:
      Tobias Ritter
    • 依托单位:
    Organometallic Chemistry for Applications in Biomedical Sciences
    • 批准号:
      8015232
    • 项目类别:
    • 资助金额:
      $32.43万
    • 财政年份:
      2010
    • 负责人:
      Tobias Ritter
    • 依托单位:
    海外基金